BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -13.3% ·
flujo de acciones -12.2% ·
nuevas posiciones netas -15.4%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | +3 | 139.01M | $1.39B | +7 | −5 |
| Q1 2026 | 108 | +4 | 130.67M | $1.24B | +14 | −10 |
| Q4 2025 | 103 | -1 | 127.11M | $991.41M | n/a | −1 |
| Q3 2025 | 22 | +2 | 89.66M | $680.51M | +2 | −1 |
| Q2 2025 | 18 | +1 | 80.75M | $723.56M | +1 | n/a |
| Q1 2025 | 14 | +1 | 26.41M | $198.06M | +1 | n/a |
| Q4 2024 | 13 | -2 | 21.17M | $159.22M | n/a | −2 |
| Q3 2024 | 14 | +4 | 16.62M | $126.32M | +4 | n/a |
| Q2 2024 | 10 | n/a | 15.77M | $97.44M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 7.50M | n/a | $56.39M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 4.82M | -0.3% | $36.28M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 3 | Fisher Asset Management ✦ | 3.18M | -4.7% | $23.93M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 1.77M | +0.8% | $13.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 839.27K | +6.6% | $6.31M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 6 | Millennium Management ✦ | 790.11K | -40.3% | $5.94M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 545.02K | -7.5% | $4.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Norges Bank ✦ (pasivo) | 524.80K | -14.2% | $3.95M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 403.41K | -6.5% | $3.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 315.26K | +37.6% | $2.37M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 258.55K | -7.4% | $1.94M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 12 | T. Rowe Price ✦ | 126.81K | -94.4% | $954,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 89.06K | -17.4% | $669,708 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Gotham Asset Management | $295,587 | era 0.0% |
| Marshall Wace | $252,753 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 298 tenedores, 245.96M acciones, $2.30B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.